Neutropenia following metamizole use in pediatric patients: a multicenter retrospective study.
作者信息
Siddiqui Meraj Alam, Akyay Arzu, Belen Apak Fatma Burcu, Carti Özgür, Albayrak Canan, İşik Melek, Kaya Zühre, Yetgin Sevgi, Olcay Lale
机构信息
Department of Pediatrics, Baskent University Faculty of Medicine, Ankara, Turkey.
Department of Pediatric Hematology Oncology, Inonu University Faculty of Medicine, Malatya, Turkey.
出版信息
Clin Exp Pediatr. 2024 Aug;67(8):415-417. doi: 10.3345/cep.2024.00262. Epub 2024 Jul 23.
Abstract
摘要
相似文献
1
Neutropenia following metamizole use in pediatric patients: a multicenter retrospective study.小儿患者使用安乃近后出现的中性粒细胞减少症：一项多中心回顾性研究。
Clin Exp Pediatr. 2024 Aug;67(8):415-417. doi: 10.3345/cep.2024.00262. Epub 2024 Jul 23.
2
Metamizole-associated neutropenia: Comparison of patients with neutropenia and metamizole-tolerant patients.甲灭酸相关性中性粒细胞减少症：中性粒细胞减少症患者与甲灭酸耐受患者的比较。
Eur J Intern Med. 2019 Oct;68:36-43. doi: 10.1016/j.ejim.2019.07.029. Epub 2019 Aug 3.
3
Metamizole and the risk of drug-induced agranulocytosis and neutropenia in statutory health insurance data.甲灭酸与法定健康保险数据中药物诱导的粒细胞缺乏症和中性粒细胞减少症的风险。
Naunyn Schmiedebergs Arch Pharmacol. 2020 Apr;393(4):681-690. doi: 10.1007/s00210-019-01774-4. Epub 2019 Dec 7.
4
A possible increased risk of metamizole-associated neutropenia among COVID-19 patients.COVID-19 患者中使用甲灭酸可能会增加中性粒细胞减少症的风险。
Br J Clin Pharmacol. 2021 Jul;87(7):2902-2906. doi: 10.1111/bcp.14703. Epub 2021 Jan 7.
5
Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition - A Descriptive Observational Retrospective Multicenter Analysis.免疫检查点抑制继发的4级中性粒细胞减少症——一项描述性观察性回顾性多中心分析
Front Oncol. 2021 Oct 21;11:765608. doi: 10.3389/fonc.2021.765608. eCollection 2021.
6
Case Report: Simultaneously Induced Neutropenia and Hemolysis After a Single Metamizole Dose.病例报告：单次使用氨基比林后同时发生中性粒细胞减少和溶血性贫血。
Drugs R D. 2023 Jun;23(2):93-98. doi: 10.1007/s40268-023-00415-9. Epub 2023 Mar 29.
7
Metamizole use by Latino immigrants: a common and potentially harmful home remedy.拉丁裔移民使用安乃近：一种常见且可能有害的家庭疗法。
Pediatrics. 2002 Jun;109(6):e98. doi: 10.1542/peds.109.6.e98.
8
NAT2 polymorphisms as a cause of metamizole-induced agranulocytosis.NAT2基因多态性是安乃近所致粒细胞缺乏症的一个病因。
Pharmacogenet Genomics. 2021 Aug 1;31(6):140-143. doi: 10.1097/FPC.0000000000000432.
9
[Agranulocytosis and septic shock after metamizole use].使用安乃近后出现粒细胞缺乏症和感染性休克
Ned Tijdschr Geneeskd. 2016;160:A9464.
10
Paediatric Agranulocytosis Associated with Metamizole Treatment.儿童中性粒细胞减少症与麦角胺治疗相关。
Paediatr Drugs. 2021 Jan;23(1):105-110. doi: 10.1007/s40272-020-00431-1. Epub 2020 Nov 28.
本文引用的文献
1
NAT2 polymorphisms as a cause of metamizole-induced agranulocytosis.NAT2基因多态性是安乃近所致粒细胞缺乏症的一个病因。
Pharmacogenet Genomics. 2021 Aug 1;31(6):140-143. doi: 10.1097/FPC.0000000000000432.
2
Neutropenia in Pediatric Infections.小儿感染中的中性粒细胞减少症
Indian J Pediatr. 2019 Nov;86(11):983-984. doi: 10.1007/s12098-019-03026-y. Epub 2019 Jul 11.
3
Leucopenia associated with metamizole: a case-control study.安乃近所致白细胞减少症：一项病例对照研究。
Swiss Med Wkly. 2017 May 24;147:w14438. doi: 10.4414/smw.2017.14438. eCollection 2017.
4
Metamizole (dipyrone)-associated agranulocytosis. An analysis of German spontaneous reports 1990-2012.安乃近相关粒细胞缺乏症。对1990年至2012年德国自发报告的分析
Eur J Clin Pharmacol. 2015 Sep;71(9):1129-38. doi: 10.1007/s00228-015-1895-y. Epub 2015 Jul 15.
5
Hematological safety of metamizole: retrospective analysis of WHO and Swiss spontaneous safety reports.安乃近的血液学安全性：对世界卫生组织和瑞士自发安全性报告的回顾性分析
Eur J Clin Pharmacol. 2015 Feb;71(2):209-17. doi: 10.1007/s00228-014-1781-z. Epub 2014 Nov 18.
6
Life-threatening agranulocytosis, anemia, and plasmacytosis after dipyrone use for fever in a child.一名儿童在使用安乃近治疗发热后出现危及生命的粒细胞缺乏症、贫血和浆细胞增多症。
J Pediatr Hematol Oncol. 2014 Jan;36(1):e46-8. doi: 10.1097/MPH.0b013e31826e7d9d.
7
Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole).粒细胞缺乏症及其他与安乃近（甲氨基苯甲酸钠）相关的血液系统异常。
Eur J Clin Pharmacol. 2002 Jul;58(4):265-74. doi: 10.1007/s00228-002-0465-2. Epub 2002 Jun 6.
Zotero 插件